TABLE 2.
Sero- type | Inhibitionb by:
|
||||||
---|---|---|---|---|---|---|---|
A (F12K) | B (F3K) | C (F2K) | D (F9K) | E (F4K) | F
|
||
F41LK | F41SK | ||||||
Ad12 | +++ | − | +++ | +++ | +++ | +++ | − |
Ad3 | − | +++ | − | − | − | − | − |
Ad2 | +++ | − | +++ | +++ | +++ | +++ | − |
Ad9 | ++ | − | ++ | ++ | ++ | ++ | − |
Ad4 | +++ | − | +++ | +++ | +++ | +++ | − |
Ad41 | +++ | − | +++ | +++ | +++ | +++ | − |
Approximately 106 A549 cells (human lung carcinoma cells) were preincubated for 1 h in 250 μl of PBS plus 2 μg of purified fiber knob protein per ml at 37°C. The cells were chilled for 10 min, and 3H-labeled serotypes were added and incubated for 1 h at 4°C. The cells were washed twice. The pellet was taken up in 100 μl of PBS, added to scintillation cocktail, and counted directly.
+++, >95% inhibition; ++, 40 to 60% inhibition; −, no inhibition.